Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q3 2026, worth $7.95M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Aytu Biopharma, Inc as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −2 vs. Q2 2026
- Shares held
- 3.71M
- −121.5K (−3.2%) vs. Q2 2026
- Total value
- $7.95M
- −$299.3K (−3.6%) vs. Q2 2026
- New holders
- 3
- 6 more added
- Sold out
- 5
- 7 more reduced
1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 35 | $7.95M |
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1,086,812 | $2.33M | 0.13% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 964,900 | $2.06M | 1.72% | +51,979+5.7% | Added |
| AWM Investment Company, Inc. | 619,574 | $1.33M | 0.13% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 261,146 | $558.9K | 0.00% | 00.0% | Unchanged |
| Crown Advisors Management, Inc. | 200,000 | $428.0K | 0.30% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 123,670 | $264.7K | 0.00% | +30,023+32.1% | Added |
| Renaissance Technologies LLC | 121,623 | $260.3K | 0.00% | +16,800+16.0% | Added |
| Diadema Partners LP | 67,186 | $143.8K | 0.05% | −81,360−54.8% | Reduced |
| Two Sigma Investments, LP | 65,513 | $140.2K | 0.00% | −39,813−37.8% | Reduced |
| Dimensional Fund Advisors LP | 50,046 | $107.1K | 0.00% | +4,720+10.4% | Added |
| Vanguard Fiduciary Trust Co | 48,144 | $103.0K | 0.00% | +1,096+2.3% | Added |
| Northern Trust Corp | 27,925 | $59.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 22,793 | $48.8K | 0.00% | 00.0% | Unchanged |
| Persistent Asset Partners Ltd | 17,166 | $36.7K | 0.01% | −20,818−54.8% | Reduced |
| Citadel Advisors LLC | 12,678 | $27.1K | 0.00% | −36,736−74.3% | Reduced |
| Daytona Street Capital LLC | 10,000 | $21.1K | 0.02% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 9,437 | $20.0K | 0.00% | −800−7.8% | Reduced |
| Nuveen, LLC | 2,101 | $4.62K | 0.00% | +2,101 | New |
| Tower Research Capital LLC (TRC) | 1,541 | $3.30K | 0.00% | −691−31.0% | Reduced |
| UBS Group AG | 895 | $1.91K | 0.00% | −1,482−62.3% | Reduced |
| Advisor Group Holdings, Inc. | 462 | $1.01K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 188 | $414 | 0.00% | +34+22.1% | Added |
| Wells Fargo & Company | 127 | $272 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 125 | $268 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 37 | $79 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 23 | $49 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 18 | $39 | 0.00% | +18 | New |
| Rockefeller Capital Management L.P. | 10 | $21 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 10 | $21 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3 | $6 | 0.00% | +3 | New |
| Vision Financial Markets LLC | 2 | $5 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $2 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −25,013−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,416−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |